Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
Nigrovic PA, Mannion M, Prince FH, Zeft A, Rabinovich CE, van Rossum MA, Cortis E, Pardeo M, Miettunen PM, Janow G, Birmingham J, Eggebeen A, Janssen E, Shulman AI, Son MB, Hong S, Jones K, Ilowite NT, Cron RQ, Higgins GC.
Nigrovic PA, et al.
Arthritis Rheum. 2011 Feb;63(2):545-55. doi: 10.1002/art.30128.
Arthritis Rheum. 2011.
PMID: 21280009
Free article.
Clinical Trial.